Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a "Toggle Switch" of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells.
Almairac F, Turchi L, Sakakini N, Debruyne DN, Elkeurti S, Gjernes E, Polo B, Bianchini L, Fontaine D, Paquis P, Chneiweiss H, Junier MP, Verrando P, Burel-Vandenbos F, Virolle T. Almairac F, et al. Among authors: polo b. Cancer Res. 2020 Aug 15;80(16):3236-3250. doi: 10.1158/0008-5472.CAN-19-0855. Epub 2020 May 4. Cancer Res. 2020. PMID: 32366479
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3.
Turchi L, Sakakini N, Saviane G, Polo B, Saurty-Seerunghen MS, Gabut M, Gouillou CA, Guerlais V, Pasquier C, Vignais ML, Almairac F, Chneiweiss H, Junier MP, Burel-Vandenbos F, Virolle T. Turchi L, et al. Among authors: polo b. Cancers (Basel). 2023 Oct 18;15(20):5038. doi: 10.3390/cancers15205038. Cancers (Basel). 2023. PMID: 37894405 Free PMC article.
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Luisa Gutierrez M, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Josef Maria Bauer D, Benjamin Mauz J, Casanova-Cabral M, Gschwantler M, Paolo Russo F, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M; cACLD-SVR Study Group (in alphabetical order). Semmler G, et al. Among authors: polo b. J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.03.015. Online ahead of print. J Hepatol. 2024. PMID: 38521170 Free article.
Encephalopathy in short bowel syndrome: a diagnostic challenge.
Martínez Navarro G, Polo B, Donat E, Masip E, Pacheco J, Adell A, Ortega P, Ribes-Koninckx C. Martínez Navarro G, et al. Among authors: polo b. Rev Esp Enferm Dig. 2023 Jan;115(1):47. doi: 10.17235/reed.2022.8826/2022. Rev Esp Enferm Dig. 2023. PMID: 35704361 Free article.
Intestinal anti-tissue transglutaminase IgA deposits as a complementary method for the diagnostic evaluation of celiac disease in patients with low-grade histological lesions.
Roca M, Donat E, Masip E, Ballester V, Gómez I, SanFelix M, Ramos D, Calvo-Lerma J, Giner-Pérez L, Bolonio M, Polo B, Ribes-Koninckx C. Roca M, et al. Among authors: polo b. Clin Exp Immunol. 2022 May 12;207(3):279-286. doi: 10.1093/cei/uxab010. Clin Exp Immunol. 2022. PMID: 35553627 Free PMC article.
30 results